Home > Insider Trading > Filing (0001140361-21-037653)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1865494	Io Biotech Inc.	IOBT	()	G7

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591046	A/S Invest Lundbeckfond	C/O Io Biotech, Inc. Ole Maaloes Veh 3 Copenhagen G7 2200		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-11-09	2,014,161	$0.00	2,014,161	No	4	C	Direct
Common Stock	Acquisiton	2021-11-09	1,892,434	$0.00	3,906,595	No	4	C	Direct
Common Stock	Acquisiton	2021-11-09	2,142,857	$14.00	6,049,452	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2021-11-09	219,595	$0.00	2,014,161	$0.00
Common Stock	Series C Preferred Stock	Disposition	2021-11-09	150,534	$0.00	1,892,434	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Upon the closing of the Issuer's initial public offering ("IPO"), each share of Series B Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series B Preferred Stock had no expiration date.
Upon the closing of the IPO, each share of Series C Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series C Preferred Stock had no expiration date.